Unless continued AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.
Kui ravi jätkamist ARB' iga ei peeta hädavajalikuks, tuleb rasestumist planeerival patsiendil antihüpertensiivne ravi asendada sellisega, mille ohutusprofiil lubab kasutamist raseduse ajal.